Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Semler Scientific Inc SMLR

Healthcare Medical Devices
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s... see more

Recent & Breaking News (NDAQ:SMLR)

Semler Scientific's Board of Directors authorizes an up to $20.0 million stock repurchase program

PR Newswire March 14, 2022

Clinical Study using QuantaFlo® published in Peer-Reviewed Journal of Vascular Surgery

PR Newswire March 1, 2022

Semler Reports Fourth Quarter and Year-to-Date 2021 Financial Results

PR Newswire February 28, 2022

Semler to Report Fourth Quarter and Year End 2021 Financial Results and Host Conference Call on February 28, 2022

PR Newswire February 17, 2022

Semler Reports Third Quarter and Year-to-Date 2021 Financial Results

PR Newswire November 1, 2021

Semler to Report Third Quarter and First Nine Months of 2021 Financial Results and Host Conference Call on November 1, 2021

PR Newswire October 22, 2021

Semler Scientific to Commence Trading on Nasdaq

PR Newswire September 27, 2021

Semler Scientific to Present at Upcoming Investor Conferences

PR Newswire August 26, 2021

Semler Reports Second Quarter and First Half of 2021 Financial Results

PR Newswire August 2, 2021

Semler to Report Second Quarter and First Half 2021 Financial Results and Host Conference Call on August 2, 2021

PR Newswire July 21, 2021

Semler to Participate in the Raymond James Human Health Innovation Conference

PR Newswire June 10, 2021

Semler Reports First Quarter 2021 Financial Results

PR Newswire May 3, 2021

Semler to Report First Quarter 2021 Financial Results and Host Conference Call on May 3, 2021

PR Newswire April 26, 2021

Semler to Participate in the 20th Annual Needham Virtual Healthcare Conference

PR Newswire April 7, 2021

Semler Reports Record Fourth Quarter and Year End 2020 Financial Results

PR Newswire March 1, 2021

Semler to Participate in the H.C. Wainwright Global Life Sciences Conference

PR Newswire February 25, 2021

Semler to Report Fourth Quarter and Year End 2020 Financial Results and Host Conference Call on March 1, 2021

PR Newswire February 22, 2021

Semler to Participate in the H.C. Wainwright BioConnect 2021 Conference

PR Newswire January 7, 2021

Semler Scientific Expands Board of Directors with Appointment of Policy Expert Cindy Moon

PR Newswire November 12, 2020

Semler Reports Record Third Quarter and Year-to-Date 2020 Financial Results

PR Newswire November 5, 2020